Retrospective Review of Documentation Practices of Hepatitis B Immunoglobulin, Birth Dose, and Vaccination at the Hospital of Birth, in Thai Nationals and Migrants in Northern Thailand.
childhood
EPI
coverage
hepatitis B
immunization
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
10
07
2019
accepted:
06
12
2019
entrez:
1
1
2020
pubmed:
1
1
2020
medline:
1
1
2020
Statut:
epublish
Résumé
Vaccination remains the mainstay of prevention of hepatitis B virus (HBV) including birth dose and hepatitis B immunoglobulins (HBIGs). National estimates of vaccination coverage exclude migrants. The objective of this study is to investigate documentation practices of HBV-related infant vaccinations in Northern Thailand including migrants. This is a retrospective review of hospital records of women who birthed infants in 2015 at Maharaj Nakorn Hospital, Chiang Mai (CM) or on the Thailand-Myanmar border, Tak. Of 2522 women, 987 were from CM (861 Thai nationals, 126 migrants) and 1535 were from Tak (651 Thai residence and 884 Myanmar residence). In CM, documentation for the birth dose vaccine (999 of 999, 100%) and HBIG was complete. In Tak, documentation was 1441 of 1549 (93%) for birth dose and 26 of 34 (76.5%) for HBIG, with missed opportunities including home delivery, delay in obtaining hepatitis B e-antigen status, and limitations of the records. Expanded Program of Immunization (EPI) documentation of 3 follow-up vaccinations dwindled with subsequent doses and distance, and complete documentation of 3 HBV EPI vaccines at the hospital of birth was low, 41.5% (1056 of 2547), but equitable for Thai or migrant status. This review provides strong support for excellent documentation of HBIG and birth dose vaccination in urban and rural settings, and in migrants, consistent with Thailand's vaccination policy and practice. Documentation of the 3 HBV EPI at the hospital of birth decreases with sequential doses, especially in families further away. Innovative data linkage is required to prove coverage and identify gaps.
Sections du résumé
BACKGROUND
BACKGROUND
Vaccination remains the mainstay of prevention of hepatitis B virus (HBV) including birth dose and hepatitis B immunoglobulins (HBIGs). National estimates of vaccination coverage exclude migrants. The objective of this study is to investigate documentation practices of HBV-related infant vaccinations in Northern Thailand including migrants.
METHODS
METHODS
This is a retrospective review of hospital records of women who birthed infants in 2015 at Maharaj Nakorn Hospital, Chiang Mai (CM) or on the Thailand-Myanmar border, Tak.
RESULTS
RESULTS
Of 2522 women, 987 were from CM (861 Thai nationals, 126 migrants) and 1535 were from Tak (651 Thai residence and 884 Myanmar residence). In CM, documentation for the birth dose vaccine (999 of 999, 100%) and HBIG was complete. In Tak, documentation was 1441 of 1549 (93%) for birth dose and 26 of 34 (76.5%) for HBIG, with missed opportunities including home delivery, delay in obtaining hepatitis B e-antigen status, and limitations of the records. Expanded Program of Immunization (EPI) documentation of 3 follow-up vaccinations dwindled with subsequent doses and distance, and complete documentation of 3 HBV EPI vaccines at the hospital of birth was low, 41.5% (1056 of 2547), but equitable for Thai or migrant status.
CONCLUSIONS
CONCLUSIONS
This review provides strong support for excellent documentation of HBIG and birth dose vaccination in urban and rural settings, and in migrants, consistent with Thailand's vaccination policy and practice. Documentation of the 3 HBV EPI at the hospital of birth decreases with sequential doses, especially in families further away. Innovative data linkage is required to prove coverage and identify gaps.
Identifiants
pubmed: 31890723
doi: 10.1093/ofid/ofz518
pii: ofz518
pmc: PMC6934156
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofz518Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1261-1264
pubmed: 30439873
Am J Trop Med Hyg. 2016 Sep 7;95(3):674-9
pubmed: 27402524
PLoS One. 2016 Mar 03;11(3):e0150499
pubmed: 26938736
Vaccine. 2016 Jul 29;34(35):4103-4109
pubmed: 27349841
Vaccine. 2018 Jan 2;36(1):6-14
pubmed: 29174317
PLoS One. 2018 Nov 5;13(11):e0206086
pubmed: 30395617
Am J Epidemiol. 1978 Feb;107(2):77-86
pubmed: 341692
BMC Public Health. 2014 Feb 26;14:203
pubmed: 24568184
Int J Gynaecol Obstet. 2014 Aug;126(2):106-10
pubmed: 24834849
BMJ. 2006 Feb 11;332(7537):328-36
pubmed: 16443611
BMC Public Health. 2010 Mar 09;10:116
pubmed: 20211034
Clin Gastroenterol Hepatol. 2012 May;10(5):452-9
pubmed: 22079509
Eur J Public Health. 2015 Dec;25(6):937-44
pubmed: 26318852
J Pregnancy. 2019 Feb 25;2019:8435019
pubmed: 30931155
Pediatrics. 1989 Jun;83(6):1041-8
pubmed: 2726331
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004790
pubmed: 16625613
Int J Gynaecol Obstet. 2018 Apr;141(1):126-132
pubmed: 29315536
Pediatrics. 2013 Apr;131(4):e1135-43
pubmed: 23530168
Bull World Health Organ. 2006 Jan;84(1):65-71
pubmed: 16501717
J Immigr Minor Health. 2016 Oct;18(5):1038-1045
pubmed: 26483180
Int J Environ Res Public Health. 2013 Jul 09;10(7):2845-56
pubmed: 23839061
Hum Vaccin Immunother. 2015;11(11):2556-63
pubmed: 26291883
J Infect Dev Ctries. 2016 Apr 28;10(4):384-8
pubmed: 27131000
PLoS One. 2017 Aug 15;12(8):e0183255
pubmed: 28809948
N Engl J Med. 2016 Jun 16;374(24):2324-34
pubmed: 27305192
Hum Vaccin Immunother. 2016 May 3;12(5):1155-63
pubmed: 27078191
Front Public Health. 2016 Mar 08;4:36
pubmed: 27014673
Indian J Med Res. 2007 Jan;125(1):31-42
pubmed: 17332655
Front Public Health. 2015 Aug 06;3:191
pubmed: 26301213
PLoS Negl Trop Dis. 2017 Oct 5;11(10):e0005842
pubmed: 28981505